← Back to Search

Dietary Supplement

Nutrient drink for Gastroparesis

N/A
Waitlist Available
Led By Pankaj J Pasricha, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2, 4 and 6 weeks
Awards & highlights

Study Summary

This trial is testing a new, high-calorie drink to see if it can help people with gastroparesis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Safety will be measured by the NIH PROMISE scale at 2 weeks
Safety will be measured by the NIH PROMISE scale at 4 weeks
Safety will be measured by the NIH PROMISE scale at 6 weeks
+4 more
Secondary outcome measures
Improvement in gastroparesis symptoms

Trial Design

1Treatment groups
Experimental Treatment
Group I: NutrientExperimental Treatment1 Intervention
Nutrient drink
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nutrient drink
2010
Completed Phase 3
~100

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,274 Previous Clinical Trials
14,840,517 Total Patients Enrolled
11 Trials studying Gastroparesis
1,228 Patients Enrolled for Gastroparesis
Pankaj J Pasricha, MDPrincipal InvestigatorJohns Hopkins University
8 Previous Clinical Trials
1,409 Total Patients Enrolled
4 Trials studying Gastroparesis
1,103 Patients Enrolled for Gastroparesis
~0 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top